Bone health in a tertiary-care gastroenterology and hepatology population

Digestive Diseases and Sciences

Volumn 55, Issue 8, 2010, Pages 2263-2269

  Long, Millie D ^a,b   Thiny, Michelle T ^a,c   Sandler, Robert S ^a,b   Gangarosa, Lisa M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c IQVIA   (United States)

Author keywords

Digestive diseases; Glucocorticoid use; Knowledge, attitudes and practices (KAP); Osteoporosis; Quality improvement

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BONE DENSITOMETRY; CONTROLLED STUDY; ENTERITIS; FEMALE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; TERTIARY HEALTH CARE;

ADULT; CALCIUM; CROSS-SECTIONAL STUDIES; DIPHOSPHONATES; FEMALE; GASTROINTESTINAL DISEASES; GLUCOCORTICOIDS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; OSTEOPOROSIS; VITAMIN D;

EID: 77954426771     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1130-8     Document Type: Article

References (22)

1. JY Reginster N Burlet 2006 Osteoporosis: a still increasing prevalence Bone 38 S4 S9 10.1016/j.bone.2005.11.024 16455317 (Pubitemid 43190767)
2. F De Vries M Bracke HG Leufkens et al. 2007 Fracture risk with intermittent high-dose oral glucocorticoid therapy Arthritis Rheum 56 208 214 10.1002/art.22294 17195223 (Pubitemid 46106193)
3. JR Curtis KG Saag 2007 Prevention and treatment of glucocorticoid-induced osteoporosis Curr Osteoporos Rep 5 14 21 10.1007/BF02938618 17320023
4. A Mudano J Allison J Hill T Rothermel K Saag 2001 Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort J Rheumatol 28 1298 1305 1:STN:280:DC%2BD38%2Fht1ehsA%3D%3D 11409123 (Pubitemid 32510502)
5. American Gastroenterological Association medical position statement 2003 Guidelines on osteoporosis in gastrointestinal diseases Gastroenterology 124 791 794 10.1053/gast.2003.50107 (Pubitemid 36268495)
6. American Gastroenterological Association medical position statement 2003 Osteoporosis in hepatic disorders Gastroenterology 125 937 940 10.1016/S0016-5085(03)01060-6 (Pubitemid 37070709)
7. Bernstein CN, S K. Guidelines for osteoporosis and inflammatory bowel disease. A guide to the diagnosis and management for the gastroenterologist (monograph). The American College of Gastroenterology 2003.
8. A Kornbluth M Hayes S Feldman et al. 2006 Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria Am J Gastroenterol 101 1546 1550 10.1111/j.1572-0241.2006.00571.x 16863559 (Pubitemid 43980628)
9. TM Winzenberg B Oldenburg S Frendin G Jones 2003 The design of a valid and reliable questionnaire to measure osteoporosis knowledge in women: the Osteoporosis Knowledge Assessment Tool (OKAT) BMC Musculoskelet Disord 4 17 10.1186/1471-2474-4-17 12877751 (Pubitemid 38809210)
10. Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001;44:1496-1503.
11. RA Adler MC Hochberg 2003 Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs Arch Intern Med 163 2619 2624 10.1001/archinte.163.21.2619 14638562 (Pubitemid 37464420)
12. JP Devogelaer S Goemaere S Boonen et al. 2006 Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club Osteoporos Int 17 8 19 10.1007/s00198-005-2032-z 1:CAS:528:DC%2BD2MXhtlWkt7rK 16217586 (Pubitemid 41798023)
13. PP Geusens RN de Nijs WF Lems et al. 2004 Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology Ann Rheum Dis 63 324 325 10.1136/ard.2003.008060 1:STN:280:DC%2BD2c7gslelsw%3D%3D 14962971 (Pubitemid 38250679)
14. BM Tang GD Eslick C Nowson C Smith A Bensoussan 2007 Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Lancet 370 657 666 10.1016/S0140-6736(07)61342-7 1:CAS:528:DC%2BD2sXpsFWrsbc%3D 17720017 (Pubitemid 47285316)
15. RN de Nijs JW Jacobs A Algra WF Lems JW Bijlsma 2004 Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies Osteoporos Int 15 589 602 10.1007/s00198-004- 1614-5 15138667 (Pubitemid 39121106)
16. V Abitbol K Briot C Roux et al. 2007 A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease Clin Gastroenterol Hepatol 5 1184 1189 10.1016/j.cgh.2007.05.016 17683996 (Pubitemid 47496232)
17. JR Curtis AO Westfall J Allison et al. 2007 Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial Arch Intern Med 167 591 596 10.1001/archinte.167.6.591 17389291 (Pubitemid 46513229)
18. RP McDonough WR Doucette P Kumbera DG Klepser 2005 An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis Value Health 8 24 31 10.1111/j.1524-4733.2005.04007.x 15841891 (Pubitemid 40293638)
19. M Naunton GM Peterson G Jones GM Griffin MD Bleasel 2004 Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis J Rheumatol 31 550 556 14994404 (Pubitemid 38337618)
20. S Kane D Reddy 2006 Guidelines do help change behavior in the management of osteoporosis by gastroenterologists Am J Gastroenterol 101 1841 1844 10.1111/j.1572-0241.2006.00662.x 16817840 (Pubitemid 44166595)
21. JH Wagnon DA Leiman GD Ayers DA Schwartz 2009 Survey of gastroenterologists' awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: are the guidelines being used and what are the barriers to their use? Inflamm Bowel Dis 15 1082 1089 10.1002/ibd.20857 19137605
22. JR Curtis AO Westfall JJ Allison et al. 2005 Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients Arthritis Rheum 52 2485 2494 10.1002/art.21194 16052570 (Pubitemid 41117436)